Amid the concerns surrounding potential rare side effects of the AstraZeneca-Oxford Covid-19 vaccine, the pharmaceutical ...

Cambridge [United Kingdom], May 1 (ANI): In light of recent concerns surrounding potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant has reiterated its ...

European safety regulators have launched an investigation into the safety of a batch of the Oxford University/AstraZeneca COVID-19 vaccine, as countries including Denmark suspended its use as a ...

Platelets are cells that help your blood clot, and it was so unusual to see blood clots combined with low platelet levels, that experts coined a new medical term: vaccine-induced thrombosis with ...

Results from a randomized control trial published Nov. 6 in JAMA Network Open show that participants who received mRNA ...

A Covid conspiracy theorist has been sentenced to five years behind bars after encouraging violence against Professor Sir ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports linking these vaccines to immune thrombotic thrombocytopenic purpura (TTP).

With a new hearing scheduled for November 27, 2024, questions persist regarding the safety of the vaccine ... several vaccines including AstraZeneca, Moderna, Pfizer-BioNTtech, Johnson and Johnson ...

Last week, AstraZeneca reiterated its commitment to patient safety while emphasising the vaccine's overall safety profile. An AstraZeneca spokesperson had stated, "Our sympathy goes out to anyone ...

Patient safety is our highest priority." The statement added that AstraZeneca’s vaccine “has continuously been shown to have an acceptable safety profile and regulators around the world ...